OEP Malaysia

Orient EuroPharma Malaysia (OEP MY) was established in 1997. Major products include: Navelbine (an injection and oral dose form) for breast and lung cancer; and Zanidip, a new generation of lipophilic calcium blocker, for chronic hypertension (benefit of avoiding edema side effect); hypertensive drugs; diabetic drug; and anti-parkinson's disease drug. In 2012, Foster for asthma and Vimpat for seizures were marketed. With so many different innovative drugs, OEP MY would certainly become one of the dominant pharmaceutical companies in Malaysia. Karihome products were launched in Malaysia in 2005, consistently leading goat milk powder products in the area. The team of Karihome products has also continuously established positive word of mouth through various activities, all in an effort to promote Karihome products for more families to enjoy. Dermo-cosmetics team was established in 2016, selling Germany’s Hyabell injectable hyaluronic acid products to expand the medical cosmetic markets in Malaysia.